Literature DB >> 24550301

Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue.

Kuan Rong Chan1, Eugenia Z Ong, Hwee Cheng Tan, Summer Li-Xin Zhang, Qian Zhang, Kin Fai Tang, Nivashini Kaliaperumal, Angeline Pei Chiew Lim, Martin L Hibberd, Soh Ha Chan, John E Connolly, Manoj N Krishnan, Shee Mei Lok, Brendon J Hanson, Chao-Nan Lin, Eng Eong Ooi.   

Abstract

Viruses must evade the host innate defenses for replication and dengue is no exception. During secondary infection with a heterologous dengue virus (DENV) serotype, DENV is opsonized with sub- or nonneutralizing antibodies that enhance infection of monocytes, macrophages, and dendritic cells via the Fc-gamma receptor (FcγR), a process termed antibody-dependent enhancement of DENV infection. However, this enhancement of DENV infection is curious as cross-linking of activating FcγRs signals an early antiviral response by inducing the type-I IFN-stimulated genes (ISGs). Entry through activating FcγR would thus place DENV in an intracellular environment unfavorable for enhanced replication. Here we demonstrate that, to escape this antiviral response, antibody-opsonized DENV coligates leukocyte Ig-like receptor-B1 (LILRB1) to inhibit FcγR signaling for ISG expression. This immunoreceptor tyrosine-based inhibition motif-bearing receptor recruits Src homology phosphatase-1 to dephosphorylate spleen tyrosine kinase (Syk). As Syk is a key intermediate of FcγR signaling, LILRB1 coligation resulted in reduced ISG expression for enhanced DENV replication. Our findings suggest a unique mechanism for DENV to evade an early antiviral response for enhanced infection.

Entities:  

Keywords:  early innate immune response; immune evasion; innate immune signaling

Mesh:

Substances:

Year:  2014        PMID: 24550301      PMCID: PMC3932915          DOI: 10.1073/pnas.1317454111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.

Authors:  Daniel H Libraty; Timothy P Endy; Huo-Shu H Houng; Sharone Green; Siripen Kalayanarooj; Saroj Suntayakorn; Wanya Chansiriwongs; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

2.  Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors.

Authors:  Ioannis Tassiulas; Xiaoyu Hu; Hao Ho; Yogita Kashyap; Paul Paik; Yongmei Hu; Clifford A Lowell; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2004-10-03       Impact factor: 25.606

Review 3.  The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?

Authors:  A M Scharenberg; J P Kinet
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

4.  Identification and characterization of a novel monocyte subpopulation in human peripheral blood.

Authors:  B Passlick; D Flieger; H W Ziegler-Heitbrock
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

5.  A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells.

Authors:  H Kubagawa; P D Burrows; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Antibody-enhanced dengue virus infection in primate leukocytes.

Authors:  S B Halstead; E J O'Rourke
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

7.  Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.

Authors:  Kobporn Boonnak; Bonnie M Slike; Gina C Donofrio; Mary A Marovich
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

8.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

Review 9.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

10.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

Authors:  S B Halstead; E J O'Rourke
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  53 in total

Review 1.  Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations.

Authors:  Kouyuki Hirayasu; Hisashi Arase
Journal:  J Hum Genet       Date:  2015-06-04       Impact factor: 3.172

2.  LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection.

Authors:  Falk Nimmerjahn; Anja Lux
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-05       Impact factor: 11.205

Review 3.  Review article: Research on dengue during World War II revisited.

Authors:  Grace E Snow; Benjamin Haaland; Eng Eong Ooi; Duane J Gubler
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

4.  Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

Authors:  Luke N Robinson; Kannan Tharakaraman; Kirk J Rowley; Vivian V Costa; Kuan Rong Chan; Yee Hwa Wong; Li Ching Ong; Hwee Cheng Tan; Tyree Koch; David Cain; Rama Kirloskar; Karthik Viswanathan; Chong Wai Liew; Hamid Tissire; Boopathy Ramakrishnan; James R Myette; Gregory J Babcock; V Sasisekharan; Sylvie Alonso; Jianzhu Chen; Julien Lescar; Zachary Shriver; Eng Eong Ooi; Ram Sasisekharan
Journal:  Cell       Date:  2015-07-16       Impact factor: 41.582

Review 5.  Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.

Authors:  Jilu Zhang; Sunny Mai; Hui-Ming Chen; Kyeongah Kang; Xian Chang Li; Shu-Hsia Chen; Ping-Ying Pan
Journal:  J Leukoc Biol       Date:  2017-03-28       Impact factor: 4.962

6.  Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus.

Authors:  Meng Ling Moi; Yasushi Ami; Kenji Shirai; Chang-Kweng Lim; Yuriko Suzaki; Yuka Saito; Kazutaka Kitaura; Masayuki Saijo; Ryuji Suzuki; Ichiro Kurane; Tomohiko Takasaki
Journal:  Am J Trop Med Hyg       Date:  2014-12-29       Impact factor: 2.345

Review 7.  Immune Response to Dengue and Zika.

Authors:  Annie Elong Ngono; Sujan Shresta
Journal:  Annu Rev Immunol       Date:  2018-01-18       Impact factor: 28.527

8.  A serological framework to investigate acute primary and post-primary dengue cases reporting across the Philippines.

Authors:  Joseph R Biggs; Ava Kristy Sy; Oliver J Brady; Adam J Kucharski; Sebastian Funk; Mary Anne Joy Reyes; Mary Ann Quinones; William Jones-Warner; Yun-Hung Tu; Ferchito L Avelino; Nemia L Sucaldito; Huynh Kim Mai; Le Thuy Lien; Hung Do Thai; Hien Anh Thi Nguyen; Dang Duc Anh; Chihiro Iwasaki; Noriko Kitamura; Lay-Myint Yoshida; Amado O Tandoc; Eva Cutiongco-de la Paz; Maria Rosario Z Capeding; Carmencita D Padilla; Julius Clemence R Hafalla; Martin L Hibberd
Journal:  BMC Med       Date:  2020-11-27       Impact factor: 8.775

9.  Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection.

Authors:  Justin B Callaway; Scott A Smith; Karen P McKinnon; Aravinda M de Silva; James E Crowe; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

Review 10.  New insights into the immunopathology and control of dengue virus infection.

Authors:  Gavin Screaton; Juthathip Mongkolsapaya; Sophie Yacoub; Catherine Roberts
Journal:  Nat Rev Immunol       Date:  2015-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.